Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wen, Beryl ^a   Combes, Valery ^a   Bonhoure, Amandine ^a   Weksler, Babette B ^b   Couraud, Pierre Olivier ^c,d,e   Grau, Georges E R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN TYROSINE KINASE; TUMOR NECROSIS FACTOR; IL6 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD CLOTTING TIME; BLOOD VESSEL PERMEABILITY; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATION; MONOCYTE; MONOCYTIC MICROPARTICLE; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTHROMBIN TIME; SIGNAL TRANSDUCTION; BRAIN; CHEMISTRY; COCULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY;

BRAIN; CELL LINE; CELL-DERIVED MICROPARTICLES; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MONOCYTES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898662017     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091597     Document Type: Article

References (62)

1. Wolf P (1967) The Nature and Significance of Platelet Products in Human Plasma. British Journal of Haematology 13: 269-288.
2. Morel O, Toti F, Morel N, Freyssinet JM (2009) Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Haematologica 94: 313-317.
3. Ogata N, Nomura S, Shouzu A, Imaizumi M, Arichi M, et al. (2006) Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 73: 241-248. (Pubitemid 44107585)
4. Trappenburg MC, van Schilfgaarde M, Frerichs FCP, Spronk HMH, ten Cate H, et al. (2011) Chronic renal failure is accompanied by endothelial activation and a large increase in microparticle numbers with reduced procoagulant capacity. Nephrology Dialysis Transplantation.
5. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, et al. (2008) Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 177: 1268-1275. (Pubitemid 351860937)
6. Pankoui Mfonkeu JB, Gouado I, Fotso Kuaté H, Zambou O, Amvam Zollo PH, et al. (2010) Elevated Cell-Specific Microparticles Are a Biological Marker for Cerebral Dysfunctions in Human Severe Malaria. PLoS ONE 5: e13415.
7. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovascular Research 59: 277-287. (Pubitemid 37272022)
8. Zwaal RFA, Schroit AJ (1997) Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells. Blood 89: 1121-1132. (Pubitemid 27079974)
9. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, et al. (1994) Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. The Journal of Immunology 153: 3245-3255. (Pubitemid 24292551)
10. Connor DE, Exner T, Ma DD, Joseph JE (2009) Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagulation & Fibrinolysis 20: 558-564 510.1097/MBC.1090b1013e32832ee32915.
11. Warkentin T, Hayward C, Boshkov L, Santos A, Sheppard J, et al. (1994) Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 84: 3691-3699.
12. Oehmcke S, Mörgelin M, Malmström J, Linder A, Chew M, et al. (2011) Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles. Cellular Microbiology: no-no.
13. Kanazawa S, Nomura S, Kuwana M, Muramatsu M, Yamaguchi K, et al. (2003) Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung cancer (Amsterdam, Netherlands) 39: 145-149.
14. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, et al. (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825-835. (Pubitemid 34008509)
15. Sarkar A, Mitra S, Mehta S, Raices R, Wewers MD (2009) Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1. PLoS ONE 4: e7140.
16. Essayagh S, Xuereb JM, Terrisse AD, Tellier-Cirioni L, Pipy B, et al. (2007) Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 98: 831-837. (Pubitemid 47555076)
17. Mastronardi ML, Mostefai HA, Soleti R, Agouni A, Martínez MC, et al. (2010) Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells. Fundamental & Clinical Pharmacology: no-no.
18. Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, et al. (2008) Circulating Microparticles from Patients with Septic Shock Exert Protective Role in Vascular Function. Am J Respir Crit Care Med 178: 1148-1155.
19. Nieuwland R, Berckmans RJ, McGregor S, Boing AN, Romijn FP, et al. (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95: 930-935. (Pubitemid 30063043)
20. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B (2003) Current Epidemiology of Septic Shock: The CUB-Rea Network. Am J Respir Crit Care Med 168: 165-172. (Pubitemid 36920969)
21. Sundararajan V, MacIsaac CM, Presneill JJ, Cade JF, Visvanathan K (2005) Epidemiology of sepsis in Victoria, Australia. Critical Care Medicine 33: 71-80 10.1097/1001.CCM.0000150027.0000198160.0000150080. (Pubitemid 40116539)
22. Pine RW, Wertz MJ, Lennard ES, Dellinger EP, Carrico CJ, et al. (1983) Determinants of Organ Malfunction or Death in Patients With Intra-abdominal Sepsis: A Discriminant Analysis. Arch Surg 118: 242-249. (Pubitemid 13181582)
23. Sprung CL, Peduzzi PN, Shatney CH, Schein RM, Wilson MF, et al. (1990) Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18: 801-806.
24. Young GB, Bolton CF, Austin TW, Archibald YM, Gonder J, et al. (1990) The encephalopathy associated with septic illness. Clin Invest Med 13: 297-304.
25. Riedemann NC, Guo R-F, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524. (Pubitemid 36597096)
26. Goldenberg NM, Steinberg BE, Slutsky AS, Lee WL (2011) Broken Barriers: A New Take on Sepsis Pathogenesis. Science Translational Medicine 3: 88ps25.
27. Marceau F, deBlois D, Petitclerc E, Levesque L, Drapeau G, et al. (2010) Vascular smooth muscle contractility assays for inflammatory and immunological mediators. International Immunopharmacology 10: 1344-1353.
28. Hollenberg SM, Guglielmi M, Parrillo JE (2007) Discordance between microvascular permeability and leukocyte dynamics in septic inducible nitric oxide synthase deficient mice. Crit Care 11: R125.
29. Bozza FA, Garteiser P, Oliveira MF, Doblas S, Cranford R, et al. (2010) Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study. J Cereb Blood Flow Metab 30: 440-448.
30. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82: 3170-3176. (Pubitemid 23334947)
31. Hillenbrand A, Knippschild U, Weiss M, Schrezenmeier H, Henne-Bruns D, et al. (2010) Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients. BMC Surgery 10: 26.
32. Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, et al. (1996) Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Critical Care Medicine 24: 392-397. (Pubitemid 26097830)
33. Ziegler-Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, et al. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41: 456-461. (Pubitemid 18080805)
34. Walters SB, Kieckbusch J, Nagalingam G, Swain A, Latham SL, et al. (2013) Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration. J Immunol 190: 669-677.
35. Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, et al. (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. The FASEB Journal.
36. Pankoui Mfonkeu JB, Gouado I, Fotso Kuate H, Zambou O, Amvam Zollo PH, et al. (2010) Elevated cell-specific microparticles are a biological marker for cerebral dysfunctions in human severe malaria. PLoS ONE 5: e13415.
37. Lou J, Dayer JM, Grau GE, Burger D (1996) Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol 26: 3107-3113. (Pubitemid 26411520)
38. Wassmer SC, Moxon CA, Taylor T, Grau GE, Molyneux ME, et al. (2011) Vascular endothelial cells cultured from patients with cerebral or uncomplicated malaria exhibit differential reactivity to TNF. Cell Microbiol 13: 198-209.
39. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, et al. (1999) In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104: 93-102. (Pubitemid 29534349)
40. Brown GT, McIntyre TM (2011) Lipopolysaccharide Signaling without a Nucleus: Kinase Cascades Stimulate Platelet Shedding of Proinflammatory IL-1β-Rich Microparticles. The Journal of Immunology.
41. Bernimoulin M, Waters EK, Foy M, Steele BM, Sullivan M, et al. (2009) Differential stimulation of monocytic cells results in distinct populations of microparticles. J Thromb Haemost 7: 1019-1028.
42. Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys JM, et al. (2011) Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J.
43. Jaiswal R, Luk F, Dalla PV, Grau GE, Bebawy M (2013) Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS ONE 8: e61515.
44. Habersberger J, Strang F, Scheichl A, Htun N, Bassler N, et al. (2012) Circulating microparticles generate and transport monomeric C-reactive protein in patients with myocardial infarction. Cardiovasc Res 96: 64-72.
45. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, et al. (2012) Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 93: 633-644.
46. del Conde I, Shrimpton CN, Thiagarajan P, López JA (2005) Tissue-factor? bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106: 1604-1611. (Pubitemid 41208572)
47. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, et al. (2006) Procoagulant Microparticles. Arteriosclerosis, Thrombosis, and Vascular Biology 26: 2594-2604.
48. Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE (2006) Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun 74: 645-653. (Pubitemid 43023120)
49. Jimenez J, Jy W, Mauro LM, Horstman LL, Ahn ER, et al. (2005) Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes. Mult Scler 11: 310-315. (Pubitemid 40775188)
50. Densmore JC, Signorino PR, Ou J, Hatoum OA, Rowe JJ, et al. (2006) Endothelium-Derived Microparticles Induce Endothelial Dysfunction and Acute Lung Injury. Shock 26: 464-471 410.1097/1001.shk.0000228791.0000210550.0000228736.
51. Wang JG, Williams JC, Davis BK, Jacobson K, Doerschuk CM, et al. (2011) Monocytic microparticles activate endothelial cells in an IL-1{beta}-dependent manner. Blood 118: 2366-2374.
52. Aharon A, Tamari T, Brenner B (2008) Monocyte-derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 100: 878-885.
53. Dean WL, Lee MJ, Cummins TD, Schultz DJ, Powell DW (2009) Proteomic and functional characterisation of platelet microparticle size classes. Thromb Haemost 102: 711-718.
54. Hu G, Minshall RD (2009) Regulation of transendothelial permeability by Src Kinase. Microvascular Research 77: 21-25.
55. Scheppke L, Aguilar E, Gariano RF, Jacobson R, Hood J, et al. (2008) Retinal vascular permeability suppression by topical application of a novel VEGFR2/ Src kinase inhibitor in mice and rabbits. The Journal of Clinical Investigation 118: 2337-2346. (Pubitemid 351872350)
56. Gorbunova EE, Gavrilovskaya IN, Pepini T, Mackow ER (2011) VEGFR2 and Src Kinase Inhibitors Suppress Andes Virus-Induced Endothelial Cell Permeability. J Virol 85: 2296-2303.
57. Orsenigo F, Giampietro C, Ferrari A, Corada M, Galaup A, et al. (2012) Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 3: 1208.
58. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, et al. (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. The Journal of Clinical Investigation 113: 885-894. (Pubitemid 38544147)
59. Angelini DJ, Hyun S-W, Grigoryev DN, Garg P, Gong P, et al. (2006) TNF-α increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. American Journal of Physiology - Lung Cellular and Molecular Physiology 291: L1232-L1245. (Pubitemid 44904530)
60. Gilleron J, Fiorini C, Carette D, Avondet C, Falk MM, et al. (2008) Molecular reorganization of Cx43, Zo-1 and Src complexes during the endocytosis of gap junction plaques in response to a non-genomic carcinogen. J Cell Sci 121: 4069-4078.
61. Wallez Y, Cand F, Cruzalegui F, Wernstedt C, Souchelnytskyi S, et al. (2007) Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site. Oncogene 26: 1067-1077.
62. Dwyer J, Le Guelte A, Galan Moya EM, Sumbal M, Carlotti A, et al. (2011) Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor. Oncogene 30: 190-200.